Mitral Valve Repair for Congenital Mitral Regurgitation in Children

선천성 승모판막 페쇄부전증이 있는 소아에서 승모판막 성형술에 대한 임상적 고찰

  • Kim, Kun-Woo (Department of Thoracic and Cardiovascular Surgey, Gil Hospital, Gacheon University of Medicine and Science) ;
  • Choi, Chang-Hyu (Department of Thoracic and Cardiovascular Surgey, Gil Hospital, Gacheon University of Medicine and Science) ;
  • Park, Kook-Yang (Department of Thoracic and Cardiovascular Surgey, Gil Hospital, Gacheon University of Medicine and Science) ;
  • Jung, Mi-Jin (Department of Thoracic and Cardiovascular Surgey, Gil Hospital, Gacheon University of Medicine and Science) ;
  • Park, Chul-Hyun (Department of Cardiothoracic Surgery, Gachon University Gil Medical Center, Heart Center) ;
  • Jeon, Yang-Bin (Department of Cardiothoracic Surgery, Gachon University Gil Medical Center, Heart Center) ;
  • Lee, Jae-Ik (Department of Thoracic and Cardiovascular Surgey, Gil Hospital, Gacheon University of Medicine and Science)
  • 김건우 (가천의과학대학교 길병원 흉부외과학교실) ;
  • 최창휴 (가천의과학대학교 길병원 흉부외과학교실) ;
  • 박국양 (가천의과학대학교 길병원 흉부외과학교실) ;
  • 정미진 (가천의과학대학교 길병원 흉부외과학교실) ;
  • 박철현 (가천의과학대학교 길병원 심장센터) ;
  • 전양빈 (가천의과학대학교 길병원 심장센터) ;
  • 이재익 (가천의과학대학교 길병원 흉부외과학교실)
  • Published : 2009.06.05

Abstract

Background: Surgery for mitral valve disease in children carries both technical and clinical difficulties that are due to both the wide spectrum of morphologic abnormalities and the high incidence of associated cardiac anomalies. The purpose of this study is to assess the outcome of mitral valve surgery for treating congenital mitral regurgitation in children. Material and Method: From 1997 to 2007, 22 children (mean age: 5.4 years) who had congenital mitral regurgitation underwent mitral valve repair. The median age of the patients was 5.4 years old and four patients (18%) were under 12 months of age. 15 patients (68%) had cardiac anomalies. There were 13 cases of ventricular septal defect, 1 case of atrial septal defect and 1 case of supravalvar aortic stenosis. The grade of the preoperative mitral valve regurgitation was II in 4 patients, III in 15 patients and IV in 3. The regurgitation was due to leaflet prolapse in 12 patients, annular dilatation in 4 patients and restrictive leaflet motion in 5 patients. The preoperative MV Z-value and the regurgitation grade were compared with those obtained at follow-up. Result: MV repair was possible in all the patients. 19 patients required reduction annuloplasty and 18 patients required valvuloplasty that included shortening of the chordae, papillary muscle splitting, artificial chordae insertion and cleft closure. There were no early or late deaths. The mitral valve regurgitation after surgery was improved in all patients (absent=10, grade I=5, II=5, III=2). MV repair resulted in reduction of the mitral valve Z-value ($2.2{\pm}2.1$ vs. $0.7{\pm}2.3$, respectively, p<0.01). During the mid-term follow-up period of 3.68 years, reoperation was done in three patients (one with repair and two with replacement) and three patients showed mild progression of their mitral reguration. Conclusion: our experience indicates that mitral valve repair in children with congenital mitral valve regurgitation is an effective and reliable surgical method with a low reoperation rate. A good postoperative outcome can be obtained by preoperatively recognizing the intrinsic mitral valve pathophysiology detected on echocardiography and with the well-designed, aggressive application of the various reconstruction techniques.

배경: 소아 환자의 승모판막 질환에 대한 외과적 치료는 그 모양의 다양성과 동반된 선천성 심장 기형 등으로 인해 기술적, 임상적으로 어렵다. 본 연구는 선천성 승모판막 폐쇄부전증 환아에서 본원에서 시행한 승모판막 성형 수술의 결과를 평가하였다. 대상 및 방법: 1997년 4월부터 2007년 10월까지 승모판막 폐쇄부전증으로 승모판막 수술을 시행한 소아 환자 22명을 대상으로 후향적으로 분석하였다. 수술 당시 환아의 평균 연령은 5.4세였고, 이 중 12개월 미만의 영아는 4명이었다. 동반된 심기형으로는 심실 중격결손이 13예로 가장 많았고, 그 외에 심방 중격결손과 판막 상부 대동맥 판막 협착증(supravalvar aortic valve stenosis)이 각각 1예 있었으며, 승모판막 페쇄부전증만 단독으로 있는 경우는 7예가 있었다. 수술 전 승모판막 페쇄부전증의 정도는 II, III, IV가 각각 4예, 15예, 3예였고, 그 원인으로 판막 탈출증(leaflet prolapse)이 12예, 판막륜 확장(annular dilatation)이 4예, 제한된 판막 움직임(restrictive leaflet motion)이 5예 있었다. 수술 전후의 페쇄부전증 정도와 승모판막륜의 Z-value를 비교함으로써 그 결과를 평가하였다. 결과: 모든 환자에서 판막 성형술이 가능했고, 수술 후 조기 사망과 만기 사망 모두 얼었다. 19예에서 판막륜 축소술(reduction annuloplasty)을 시행하였고, 18예에서 건삭 축소술(shortening of chordae)이나 판막열 봉합술(cleft closure) 등의 판막 성형술(valvuloplasty)은 추가로 시행하였다. 수술 직후 승모판막 폐쇄부전증의 정도는 줄어들었고(0=10, I=5, II=5, III=2), 승모판막륜의 Z-value도 감소하였다($2.2{\pm}2.1$ vs $0.7{\pm}2.3$, p<0.01). 3.68년의 추적기간 동안 3명의 환아가 승모판막 폐쇄부전증으로 재수술을 받았고, 한명은 재성형술을, 나머지 2명은 승모판막 치환술을 받았으며, 퇴원 시 3명의 환아에서 수술 직 후 보다 폐쇄부전증이 좀 더 진행되었다. 결론: 소아의 승모판막 페쇄부전증에서 일차 수술방법으로 적극적인 승모판막 성형술은 효과적이고 믿을만한 방법이다. 좀 더 좋은 수술 결과를 얻기 위해서는 수술 전 환아의 승모판막의 모양과 기능을 면밀히 파악하고, 다양한 수술적 기법을 적용하는 노력이 필요하겠다.

Keywords

References

  1. Carpentier A. Congenital malformations of the mitral valve. In: Stark J, de Leval M. Surgery for congenital heart defects. Philadelphia, PA: W.B. Saunders. 1994;599-614
  2. Beierlein W, Becker V, Yates R, et al. Long-term follow after mitral valve replacement in childhood: poor event-free survival in the young child. Eur J Cardiothorac Surg 2007; 31:860-5 https://doi.org/10.1016/j.ejcts.2007.02.006
  3. Kojori F, Chen R, Caldarone CA, et al. Outcomes of mitral valve replacement in children: a competing-risks analysis. J Thorac Cardiovasc Surg 2004;128:703-9 https://doi.org/10.1016/j.jtcvs.2004.07.024
  4. Stellin G, Padalino M, Milanesi O, et al. Repair of congenital mitral valve dysplasia in infants and children: is it always possible? Eur J Cardiothorac Surg 2000;18:74-82 https://doi.org/10.1016/S1010-7940(00)00457-7
  5. Zias EA, Mavroudis C, Backer CL, Kohr LM, Gotteniner NL, Rocchini AP. Surgical repair of the congenitally malformed mitral valve in infants and children. Ann Thorac Surg 1998;66:1551-9 https://doi.org/10.1016/S0003-4975(98)00933-3
  6. Minami K, Kado H, Sai S, et al. Midterm results of mitral valve repair with artificial chordae in children. J Thorac Cardiovasc Surg 2005;129:336-42 https://doi.org/10.1016/j.jtcvs.2004.10.016
  7. Boon R, Hazekamp M, Hoohenkerk G. Artificial chordae for pediatric mitral and tricuspid valve repair. Eur J Cardiothorac Surg 2007;32:143-8 https://doi.org/10.1016/j.ejcts.2007.03.035
  8. Chauvaus S, Fuzellier JF, Houel R, Berrebi A, Mihaileanu S, Carpentier A. Reconstructive surgery in congenital mitral valve insufficiency (Carpentier's technique): long-term results. J Thorac Cardivasc Surg 1998;115:84-93 https://doi.org/10.1016/S0022-5223(98)99001-8
  9. McCarthy JF, Neligan MC, Wood AE. Ten years’ experience of an aggressive reparative approach to congenital mitral valve anomalies. Eur J Cardiothorac Surg 1996;10:534-9 https://doi.org/10.1016/S1010-7940(96)80420-9
  10. Sugita T, Ueda Y, Matumoto M, Ogino H, Nishigawa JI, Matsuyama K. Early and late results of partial plication annuloplasty for congenital mitral insufficiency. J Thorac Cardivasc Surg 2001;122:229-33 https://doi.org/10.1067/mtc.2001.115157
  11. Prifti E, Vanini V, Bonacchi M, et al. Repair of congenital malformations of the mitral valve: early and midterm results. Ann Thorac Surg 2002;73:614-21 https://doi.org/10.1016/S0003-4975(01)03419-1
  12. Matsumoto T, Kado H, Masuda M, et al. Clinical results of mitral valve repair by reconstructing artificial chordae tendineae in children. J Thorac Cardiovasc Surg 1999;118:94-8 https://doi.org/10.1016/S0022-5223(99)70147-9